In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Demegen to acquire Periodontix
Valentis initiates gene therapy clinical trial
Angiotech initiates MS Phase II clinical
StressGen Initiates Phase II clinical trial of HspE7
Aronex Pharmaceuticals initiates Annamycin clinical
Repligen initiates secretin clinical trials
IDEC initiates rheumatoid arthritis study
SANGART INITIATES PHASE II CLINICAL TRIAL FOR HEMOSPAN™ AND ANNOUNCES NEW GRANT FUNDING
MethylGene initiates Phase I trials of novel cancer therapeutic
SkyePharma's Partner Astralis Initiates US Phase II Trial for Novel Psoriasis Treatment
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
